Suresh K. Balani
Drug Metabolism and Pharmacokinetics
Non-Clinical Development Sciences
Millennium Pharmaceuticals
The Takeda Oncology Company
USA
Name/email consistency: high
- Proposed new addition to 3Rs for ethical and humane use of rats in pharmacokinetic studies--'Recycle'. Balani, S.K., Lu, C., Cardoza, K., Berg, C., Zhang, J., Lee, F.W. Drug. Metab. Lett (2008)
- Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry. Balani, S.K., Nagaraja, N.V., Qian, M.G., Costa, A.O., Daniels, J.S., Yang, H., Shimoga, P.R., Wu, J.T., Gan, L.S., Lee, F.W., Miwa, G.T. Drug Metab. Dispos. (2006)
- Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling. Balani, S.K., Li, P., Nguyen, J., Cardoza, K., Zeng, H., Mu, D.X., Wu, J.T., Gan, L.S., Lee, F.W. Drug Metab. Dispos. (2004)
- Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Balani, S.K., Zhu, T., Yang, T.J., Liu, Z., He, B., Lee, F.W. Drug Metab. Dispos. (2002)









